Brett Prigaro
5Patents
1h-index
22Co-inventors
40Inventor score
Filing activity: Jan 18, 2019 → May 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11414404B2 | Compounds for the treatment of BRAF-associated diseases and disorders | Human Necessities | 4 | Active |
| US11964988B2 | Fused heterocyclic compounds as RET kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11634409B2 | Compounds for the treatment of BRAF-associated diseases and disorders | Human Necessities | 0 | Active |
| US11603374B2 | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors | Human Necessities | 0 | Active |
| US11524963B2 | Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.